
Mondae Review
Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 7.8/10
Best for: a low flat compounded GLP-1 price that does not rise as your dose increases
Price is where Mondae scores best in our breakdown.
Semaglutide
Tirzepatide
What the monthly price covers
Medication
Included
Provider visits
Not stated
Shipping
Included
Lab work
Not stated
Coaching
Not stated
No insurance needed · Vetted by our editors
Mondae is a compounded GLP-1 telehealth platform run by Mondae LLC, with care delivered through Bask Telehealth. Compounded semaglutide is $87 a month and compounded tirzepatide $126 a month on the month-to-month plan, with lower rates on prepaid 3- and 6-month plans, and the price does not rise as your dose increases. It also offers sermorelin, NAD+ and glutathione injections from $95 a month.
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. How we make money
Vetted alternatives to Mondae
Ro
Best for: FDA-approved brand GLP-1s, including the Wegovy pill and Foundayo, with insurance help
Editorial score · methodology
Collective
Best for: the lowest flat medication price if you can absorb an annual membership fee
Editorial score · methodology
CoreAge Rx
Best for: lowest-price compounded semaglutide and tirzepatide with one flat price at every dose
Editorial score · methodology
Mondae at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Semaglutide, Tirzepatide
- Starting price
- $87/mo
- Pricing model
- Flat: dose increases don't raise the monthly price
- What's included
- Medication · Shipping
- Availability
- All 50 states
- FDA status
- No FDA warning letter on record
How we scored Mondae
Each dimension is scored algorithmically from Mondae’s published pricing, drugs offered, verification status, and disclosed inclusions, using the same six-dimension framework we apply to every provider.
Value25%
9.2/10At $87/mo, Mondae runs about 51% below the $179 median for GLP-1 providers (each program's lowest listed ongoing monthly price for compounded semaglutide). Pricing is flat across doses, so there is no escalation markup as you titrate up.
Effectiveness25%
8.0/10Mondae offers both semaglutide and tirzepatide, the two GLP-1 molecules with the strongest published weight-loss trial outcomes.
User Experience15%
7.1/10Online intake and platform experience; 8 platform features disclosed.
Trust & Safety15%
7.2/10Core details confirmed by our editors; no FDA warning letters on file.
Accessibility10%
8.2/10Mondae treats patients in all 50 states.
Support10%
5.8/10Mondae provides standard clinician follow-up; no extended coaching or community program is disclosed.
Each checked against the provider’s own site.
Providers that don’t post pricing up front score lower on Value and carry a cost-transparency note in their review. Read the full methodology →
How we verified this Mondae review
Last checked November 2026- Confirmed current pricing across 2 dose/plan tiers
- Confirmed availability in all 50 states
- Confirmed what the monthly price does and doesn't include
- Checked the FDA warning-letter database for enforcement actions
- Walked the provider's public sign-up flow, stopping before payment
Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records. See the sources below. Editorial confidence in this data: medium.
What we checked
- Provider's own pricing page
- $87–$126/mo across 2 dose/plan tiers (checked November 2026)
- State pharmacy licensing & LegitScript status
- LegitScript Verified
- FDA warning-letter register
- No letter on file for this provider
What to expect when you sign up with Mondae
We walked Mondae’s public signup flow in October 2026 to document the process (the steps, pricing transparency, and what’s required) before you commit. (We don’t create accounts, enter medical information, or check out; this is the observable funnel, not a prescribing outcome.)
- 1Treatment pages show the monthly price and 1, 3 and 6-month plan options before any intake
- 2Switching plan length updates the per-month rate and shows the upfront total for longer plans
- 3Get started opens an 11-step online intake
- 4The first question asks whether you have taken a GLP-1 before; we stopped at this health question
- The price does not change with dose, and the page says so plainly
- The pharmacy picker and the named pharmacy list that used to sit on the treatment page are gone
- The homepage leads with 6-month prepaid rates rather than the monthly price
- The intake shows a 4.8 Trustpilot rating that does not match Mondae's Trustpilot profile
- The FAQ and the refund policy disagree on whether you pay anything if you are not prescribed
Mondae customer support
- support@mondae.com
- Hours
- 8am-8pm ET
GLP-1 medications Mondae offers
Tap any medication to read our plain-English guide: how it works, dosing, side effects, and what the trials found.
Peptides Mondae offers
Beyond GLP-1s, Mondae also offers these peptides. Tap any for our evidence-based guide.
Pricing
Prices re-verified
$87 per month on the one-month plan. Longer plans: 3-mo $75/mo ($225 total), 6-mo $69/mo ($414 total). Same price at every dose.
$126 per month on the one-month plan. Longer plans: 3-mo $124/mo ($372 total), 6-mo $114/mo ($684 total). Same price at every dose.
Ready to get started?
Plans and promotions change often, so check Mondae's current pricing and active discounts before you decide.
What we like
- One low price at every dose: $87 a month for semaglutide and $126 for tirzepatide on the monthly plan
- Prepaid 3- and 6-month plans lower the rate further, down to $69 a month for semaglutide
- Prices and plan options are published before any intake, with no membership fee
- Shipping is included in the price
- Carries a LegitScript seal for its website
- Available in all 50 states through state-licensed clinicians
Watch-outs
- Refunds are not guaranteed and the Terms state fees are not refundable in whole or in part
- Orders can only be canceled before the medication is dispensed or shipped
- The FAQ says you are not charged unless approved, but the refund policy says consultation fees are kept even if nothing is prescribed
- The homepage cards show 6-month prepaid rates ($69 and $114) while the monthly plan costs $87 and $126
- The intake says "Rated 4.8 out of 5 on Trustpilot" while Mondae's Trustpilot page shows a much lower score
- The site no longer names the pharmacies that fill your prescription
Is Mondae worth it?
The short version of what Mondae offers is a low flat compounded GLP-1 price that does not rise as your dose increases. It runs $87/month at every dose, toward the affordable end of the category, so cost isn't the reason to look elsewhere. Its flat, all-dose pricing helps anyone worried about cost climbing as they titrate up.
Mondae charges the same price at every dose. It also charges no membership fee and is LegitScript-certified.
How much Mondae costs
Compounded semaglutide runs $87/month and compounded tirzepatide runs $126/month.
That puts Mondae below the roughly $179 median across the GLP-1 providers we track (each program's lowest listed ongoing monthly price for compounded semaglutide), which is a cost advantage you can count on.
Medications: what Mondae prescribes
Mondae prescribes semaglutide (the active drug in Wegovy and Ozempic) and tirzepatide (the active drug in Zepbound and Mounjaro), the two most-studied weight-loss molecules on the market today. Rather than brand-name pens, you get a compounded formulation from a licensed pharmacy, which is why the monthly cost is lower. Just know compounded drugs aren't FDA-approved as finished products, the standard caveat in this market.
Who Mondae is best for, and who should skip it
A good fit if you…
- are focused on the lowest ongoing monthly cost: $87/month is below the roughly $179 median we track across the category (each program's lowest listed ongoing monthly price).
- live anywhere in the US and want the certainty that your state is already covered.
Look elsewhere if you…
- specifically want an FDA-approved brand-name pen instead of a compounded formulation, which this provider doesn't fill.
- need to bill insurance, since like most of this market it's cash-pay with no claims filed on your behalf.
Trust, safety, and medical oversight
Mondae treats patients in all 50 states, and we found no FDA warning letter on file for it. As with any compounded program, the most important step you can take is confirming which licensed pharmacy fills your prescription and what's in the formulation, and we explain how in our scoring methodology.
Bottom line
Mondae earns its place on the shortlist mainly on price: at $87/month it's one of the more affordable ways to stay on a GLP-1, without obvious corners cut on access or oversight. If you're comparison-shopping, altRX is one of the closest alternatives we track; compare the two before deciding.
The Bottom Line
Price is where Mondae scores best in our breakdown.
Ready to start with Mondae?
From $87/mo. See current pricing and start your free consultation.
Mondae might not be your best fit if…
We rank editorially, so here’s where a different provider we track may serve you better.
Head-to-head
Compare Mondae vs…
Mondae scores7.8/10
Side-by-side pricing, medications and scores. Pick a matchup.
Mondae vs Amazon One Medical
Amazon One Medical scores 8.5/10

Mondae vs Vytora Health
Vytora Health scores 8.4/10
Scores are our independent editorial ratings out of 10.
Frequently Asked Questions
Key terms, explained
New to GLP-1s? Tap any term for a quick, plain-English definition.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
The primary regulatory filings and peer-reviewed studies cited throughout this Mondae review:
Sources & methodology (as of November 2026)
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
See Mondae's current pricing
Plans from $87/mo. Start your free consultation to check eligibility and today's price.